Paragon 28 filed with the SEC on Friday, September 24. It provides innovative solutions to improve the treatment of even the most difficult foot and ankle conditions.
The company will list on NYSE (FNA ticker). BofA Securities, Piper Sandler & Co., Canaccord Genuity, JMP Securities, Needham & Company are acting as underwriters.
Paragon 28 stocks were first introduced on our platform in December 2020. Back then its share was worth $41.14 with the company’s valuation approximating $550 million.
We are currently waiting for more details of the coming listing. Stay tuned!